@article{rolland_b_phone-based_2017,
title = {Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol},
volume = {16},
issn = {1474-0338},
url = {http://www.ncbi.nlm.nih.gov/pubmed/27984918},
DOI = {10.1080/14740338.2017.1270939},
Language = {English},
Journal = {Expert Opin. Drug Saf.},
author = {{Rolland B} and {Auffret M} and {Labreuche J} and {Lapeyre-Mestre M} and {Dib M} and {Kemkem A} and {Grit I} and {Drelon M} and {Duhamel A} and {Cabe N} and {Vabret F} and {Guillin O} and {Baguet A} and {Masquelier C} and {Dervaux A} and {Deheul S} and {Bordet R} and {Carton L} and {Cottencin O} and {Jardri R} and {Gautier S}},
year = {2017},
keywords = {Alcohol Drinking/prevention & control, Alcoholism/drug therapy*, Algorithms, Baclofen/administration & dosage, Baclofen/adverse effects*, Cohort Studies, Drug Monitoring/methods, Follow-Up Studies, France, GABA-B Receptor Agonists/administration & dosage, GABA-B Receptor Agonists/adverse effects*, Humans, Off-Label Use, Prospective Studies, Surveys and Questionnaires, Telephone*},
pages = {125-132}
}

{"_id":"tXhxpWeRxrHiQD2rB","bibbaseid":"rollandb-auffretm-labreuchej-lapeyremestrem-dibm-kemkema-griti-drelonm-etal-phonebasedsafetymonitoringofthefirstyearofbaclofentreatmentforalcoholusedisorderthebaclophonecohortstudyprotocol-2017","authorIDs":[],"author_short":["Rolland B","Auffret M","Labreuche J","Lapeyre-Mestre M","Dib M","Kemkem A","Grit I","Drelon M","Duhamel A","Cabe N","Vabret F","Guillin O","Baguet A","Masquelier C","Dervaux A","Deheul S","Bordet R","Carton L","Cottencin O","Jardri R","Gautier S"],"bibdata":{"bibtype":"article","type":"article","title":"Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol","volume":"16","issn":"1474-0338","url":"http://www.ncbi.nlm.nih.gov/pubmed/27984918","doi":"10.1080/14740338.2017.1270939","language":"English","journal":"Expert Opin. Drug Saf.","author":[{"firstnames":[],"propositions":[],"lastnames":["Rolland B"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Auffret M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Labreuche J"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Lapeyre-Mestre M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Dib M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Kemkem A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Grit I"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Drelon M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Duhamel A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Cabe N"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Vabret F"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Guillin O"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Baguet A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Masquelier C"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Dervaux A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Deheul S"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Bordet R"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Carton L"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Cottencin O"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Jardri R"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Gautier S"],"suffixes":[]}],"year":"2017","keywords":"Alcohol Drinking/prevention & control, Alcoholism/drug therapy*, Algorithms, Baclofen/administration & dosage, Baclofen/adverse effects*, Cohort Studies, Drug Monitoring/methods, Follow-Up Studies, France, GABA-B Receptor Agonists/administration & dosage, GABA-B Receptor Agonists/adverse effects*, Humans, Off-Label Use, Prospective Studies, Surveys and Questionnaires, Telephone*","pages":"125-132","bibtex":"@article{rolland_b_phone-based_2017,\r\ntitle = {Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol},\r\nvolume = {16},\r\nissn = {1474-0338},\r\nurl = {http://www.ncbi.nlm.nih.gov/pubmed/27984918},\r\nDOI = {10.1080/14740338.2017.1270939},\r\nLanguage = {English},\r\nJournal = {Expert Opin. Drug Saf.},\r\nauthor = {{Rolland B} and {Auffret M} and {Labreuche J} and {Lapeyre-Mestre M} and {Dib M} and {Kemkem A} and {Grit I} and {Drelon M} and {Duhamel A} and {Cabe N} and {Vabret F} and {Guillin O} and {Baguet A} and {Masquelier C} and {Dervaux A} and {Deheul S} and {Bordet R} and {Carton L} and {Cottencin O} and {Jardri R} and {Gautier S}},\r\nyear = {2017},\r\nkeywords = {Alcohol Drinking/prevention & control, Alcoholism/drug therapy*, Algorithms, Baclofen/administration & dosage, Baclofen/adverse effects*, Cohort Studies, Drug Monitoring/methods, Follow-Up Studies, France, GABA-B Receptor Agonists/administration & dosage, GABA-B Receptor Agonists/adverse effects*, Humans, Off-Label Use, Prospective Studies, Surveys and Questionnaires, Telephone*},\r\npages = {125-132}\r\n}\r\n\r\n","author_short":["Rolland B","Auffret M","Labreuche J","Lapeyre-Mestre M","Dib M","Kemkem A","Grit I","Drelon M","Duhamel A","Cabe N","Vabret F","Guillin O","Baguet A","Masquelier C","Dervaux A","Deheul S","Bordet R","Carton L","Cottencin O","Jardri R","Gautier S"],"key":"rolland_b_phone-based_2017","id":"rolland_b_phone-based_2017","bibbaseid":"rollandb-auffretm-labreuchej-lapeyremestrem-dibm-kemkema-griti-drelonm-etal-phonebasedsafetymonitoringofthefirstyearofbaclofentreatmentforalcoholusedisorderthebaclophonecohortstudyprotocol-2017","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/27984918"},"keyword":["Alcohol Drinking/prevention & control","Alcoholism/drug therapy*","Algorithms","Baclofen/administration & dosage","Baclofen/adverse effects*","Cohort Studies","Drug Monitoring/methods","Follow-Up Studies","France","GABA-B Receptor Agonists/administration & dosage","GABA-B Receptor Agonists/adverse effects*","Humans","Off-Label Use","Prospective Studies","Surveys and Questionnaires","Telephone*"],"downloads":0},"bibtype":"article","biburl":"https://pro.univ-lille.fr/fileadmin/user_upload/pages_pros/patrick_devos/duhamel.bib","creationDate":"2019-06-21T09:30:54.900Z","downloads":0,"keywords":["alcohol drinking/prevention & control","alcoholism/drug therapy*","algorithms","baclofen/administration & dosage","baclofen/adverse effects*","cohort studies","drug monitoring/methods","follow-up studies","france","gaba-b receptor agonists/administration & dosage","gaba-b receptor agonists/adverse effects*","humans","off-label use","prospective studies","surveys and questionnaires","telephone*"],"search_terms":["phone","based","safety","monitoring","first","year","baclofen","treatment","alcohol","use","disorder","baclophone","cohort","study","protocol","rolland b","auffret m","labreuche j","lapeyre-mestre m","dib m","kemkem a","grit i","drelon m","duhamel a","cabe n","vabret f","guillin o","baguet a","masquelier c","dervaux a","deheul s","bordet r","carton l","cottencin o","jardri r","gautier s"],"title":"Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol","year":2017,"dataSources":["Tt6zYqvN5kE3wbwiR"]}